Genmab A/S Sponsored ADR GMAB

35.32 0.49 1.41% as of 25 Sep
Market cap
$20.8B
P/E
27.8×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
3,720.00 3,121.00 2,392.03 2,066.65 1,349.49 1,549.01 804.36 479.18 380.84 257.59
Revenue Growth
19.19% 30.48% 15.74% 53.14% (12.88%) 92.58% 67.86% 25.82% 47.85% (32.36%)
Cost of Revenue
238.00 143.00 32.82 — — — — — — —
Gross Profit
3,482.00 2,978.00 2,359.21 2,066.65 1,349.49 1,549.01 804.36 479.18 — —
R&D Expenses
1,606.00 1,414.00 1,107.88 787.58 665.20 480.59 357.66 226.70 129.63 87.94
SG&A Expenses
626.00 549.00 478.72 378.92 204.13 101.27 51.27 33.85 23.67 14.47
Operating Income
1,065.00 972.00 772.61 900.15 480.16 967.15 395.44 218.64 — —
Interest Expense (Operating)
— — — — — — — — 0.48 0.00
Non-operating Income/Expense
139.00 354.00 45.88 96.00 153.53 (62.66) 33.13 36.70 (45.25) 8.94
Non-operating Interest Expenses
269.00 291.00 136.78 96.29 111.69 238.69 1.05 1.79 6.60 4.68
EBT
1,204.00 1,326.00 818.49 996.16 633.70 904.49 428.56 255.34 171.34 160.28
Income Tax Provision
241.00 193.00 186.58 214.24 155.12 175.57 103.88 22.15 (6.44) (8.09)
Income after Tax
963.00 1,133.00 631.91 781.92 478.57 728.93 324.68 233.19 — —
Net Income Common
963.00 1,133.00 631.91 781.92 478.57 728.93 324.68 233.19 177.78 168.37
EPS (Basic)
1.55 1.77 0.97 1.16 0.73 1.12 0.52 0.38 2.92 2.81
EPS (Diluted)
1.54 1.76 0.96 1.15 0.72 1.12 0.51 0.38 2.86 2.73
Shares (Basic, Weighted)
621.51 641.87 653.10 653.87 653.96 651.79 629.63 612.63 619.02 603.87
Shares (Diluted, Weighted)
626.92 646.56 659.15 660.10 660.46 658.86 636.37 620.37 629.17 624.00
Gross Margin
93.60% 95.42% 98.63% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 0.00%
EBIT Margin
28.63% 31.14% 32.30% 43.56% 35.58% 62.44% 49.16% 45.63% 115.52% 115.97%
EBT margin
32.37% 42.49% 34.22% 48.20% 46.96% 58.39% 53.28% 53.29% 44.99% 62.22%
Net Profit Margin
25.89% 36.30% 26.42% 37.83% 35.46% 47.06% 40.37% 48.66% 46.68% 65.36%
Free Cash Flow Margin
(163.55%) 33.80% 42.52% 24.63% 23.30% 60.59% 22.64% 17.77% 67.19% 18.06%
EBITDA
1,136.00 1,032.00 815.44 951.41 519.62 1,006.83 416.27 232.51 227.70 155.18
EBIT
1,065.00 972.00 772.61 900.15 480.16 967.15 395.44 218.64 439.94 298.72
Income from Continuous Operations
963.00 1,133.00 631.91 781.92 478.57 728.93 324.68 233.19 — —
Consolidated Net Income/Loss
963.00 1,133.00 631.91 781.92 478.57 728.93 324.68 233.19 177.78 168.37
EPS (Basic, from Continuous Ops)
1.55 1.77 0.97 1.20 0.73 1.12 0.52 0.38 — —
EPS (Basic, Consolidated)
1.55 1.77 0.97 1.20 0.73 1.12 0.52 0.38 — —
EPS (Diluted, from Cont. Ops)
1.54 1.75 0.96 1.18 0.72 1.11 0.51 0.38 — —
Shares (Diluted, Average)
626.16 646.33 659.15 653.88 660.46 651.78 636.37 62.04 — —
EPS (Diluted, Consolidated)
1.54 1.75 0.96 1.18 0.72 1.11 0.51 0.38 — —
EBITDA Margin
30.54% 33.07% 34.09% 46.04% 38.51% 65.00% 51.75% 48.52% 59.79% 60.24%
Operating Cash Flow Margin
31.88% 36.08% 44.80% 26.80% 26.27% 63.62% 24.71% 33.55% 67.19% 18.06%

Fold the line items

In millions of $ except per-share values · columns are period end dates